Moderna’s vaccine in children is a quarter of the dose used for adults.
Moderna said it plans to seek emergency use authorization from the U.S. Food and Drug Administration for its COVID-19 vaccine in children under age 6.
The company released clinical trial data Wednesday showing neutralizing antibody levels were similar to those seen in adults.
The vaccine in children is a two-dose, 25-microgram shot, about a quarter of the dose used for adults.
This is a breaking news story. Please check back for updates.